Dimensional Fund Advisors LP Sells 37,769 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Dimensional Fund Advisors LP reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 7.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 469,051 shares of the company’s stock after selling 37,769 shares during the period. Dimensional Fund Advisors LP owned approximately 1.97% of OrthoPediatrics worth $13,490,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Wellington Management Group LLP bought a new stake in OrthoPediatrics during the 4th quarter valued at about $10,214,000. Granahan Investment Management LLC increased its position in shares of OrthoPediatrics by 30.0% during the fourth quarter. Granahan Investment Management LLC now owns 769,245 shares of the company’s stock valued at $25,008,000 after acquiring an additional 177,640 shares in the last quarter. Kennedy Capital Management LLC purchased a new position in OrthoPediatrics in the 1st quarter worth approximately $2,894,000. Wasatch Advisors LP boosted its stake in OrthoPediatrics by 21.2% during the 1st quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock valued at $14,618,000 after purchasing an additional 87,657 shares during the last quarter. Finally, AWM Investment Company Inc. raised its stake in shares of OrthoPediatrics by 14.6% in the first quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock worth $14,219,000 after purchasing an additional 62,000 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of OrthoPediatrics stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total transaction of $293,000.00. Following the sale, the general counsel now owns 77,304 shares in the company, valued at $2,265,007.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 31.80% of the stock is currently owned by corporate insiders.

OrthoPediatrics Stock Performance

Shares of NASDAQ KIDS opened at $25.93 on Friday. OrthoPediatrics Corp. has a 1 year low of $23.10 and a 1 year high of $36.23. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The stock has a market cap of $617.89 million, a PE ratio of -27.01 and a beta of 1.17. The firm has a fifty day moving average price of $29.16 and a 200-day moving average price of $30.19.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.08. OrthoPediatrics had a negative return on equity of 5.44% and a negative net margin of 14.35%. The firm had revenue of $52.80 million during the quarter, compared to analyst estimates of $52.40 million. Equities analysts anticipate that OrthoPediatrics Corp. will post -0.92 earnings per share for the current fiscal year.

Analyst Ratings Changes

KIDS has been the topic of several research analyst reports. Needham & Company LLC restated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research note on Friday, September 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Truist Financial reiterated a “hold” rating and issued a $34.00 price objective (up previously from $30.00) on shares of OrthoPediatrics in a research note on Friday, September 13th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.